Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus

Clinical Transplantation

Volumn 11, Issue 1, 1997, Pages 66-70

  Singh, Nina ^a,b   Gayowski, Timothy ^a   Wagener, Marilyn M ^a   Marino, Ignazio R ^a  

^a VA Healthcare VISN 4   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cryptcoccus; Fungi; Liver transplants; Neoformans

Indexed keywords

TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTIPLE ORGAN FAILURE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SHOCK; SKIN INFECTION; UNITED STATES;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; CRYPTOCOCCOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TACROLIMUS; UNITED STATES;

EID: 0031034885     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. SCHROTER GPJ, HOELSCHER M, PUTNAM CW, PORTER KA, STARZL TE. Fungus infections after liver transplantation. Ann Surg 1977: 186: 115.
2. CASTALDO P, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991: 126: 149.
3. PAYA CV, HERMANS PE, WASHINGTON JA, SMITH TF, ANHALT JP, WIENER RH, KROM RAF. Incidence, distribution and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989: 64: 555.
4. EMMONS CW. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columbia livia). Am J Hyg 1955: 62: 227.
5. CURRIE BP, FREUNDLICH LF, CASADEVALL A. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol 1994: 32: 1188.
6. PERFECT JR, DURACK DT, GALLIS HA. Cryptococcemia. Medicine (Baltimore) 1983: 62: 98.
7. TOLLEMAR J, ERICZON BG, HOLMBERG K, ANDERSON J. The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transpl Proc 1990: 22: 242.
8. BRIEGEL J, et al. Risk factors for systemic fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis 1995: 14: 375.
9. WADE JJ, ROLANDO N, HAYLLAR K, PHILPOTT-HOWARD J, CASEWELL MW, WILLIAMS R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995: 21: 1328.
10. MORA NP, GONWA TA, GOLDSTEIN RM, HUSBERG BS, KLINTMALM GB. Risk of postoperative infection after liver transplantation: a univariate and stepwise logistic regression analysis of risk factors in 150 consecutive patients. Clin Transpl 1992: 46: 443.
11. COLONNA JO, et al. Infectious complications in liver transplantation. Arch Surg 1988: 123: 360.
12. GREEN M, MICHAELS MG. Infectious complications of solid-organ transplantation in children. Adv Pediatr Infect Dis 1992: 7: 181.
13. CARREY Z, MANE S, GREIGER P. Cryptococcal meningitis as presenting symptom in pediatric AIDS (Abstract #1229). Interscience conference on antimicrobial agents and chemotherapy, Orlando, FL, 1994.
14. GADEBUSCH HH, GIKAS PW. The effect of cortisone upon experimental pulmonary Cryptococcosis. Am Rev Respir Dis 1965: 92: 64.
15. SAYLER WR, SAYLER DC, BAKER RD. Primary complex of Cryptococcus and pulmonary lymph nodes. J Infect Dis 1974: 130: 74.
16. SHUPBACH CW, WHEELER CE, BRIGGAMAN RA. WARNER NA, KANOF EP. Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol 1976: 112: 1734.
17. ROOK A, WOODS B. Cutaneous cryptococcosis. Br J Dermatol 1962: 74: 43.
18. OCHIAI T, et al. Effect on a new immunosuppressive agent, FK506, on heterotropic cardiac allotransplantation in the rat. Transpl Proc 1987: 19: 1284.
19. HIGH KP. The antimicrobial activities of cyclosporine, FK506, and rapamycin. Transplantation 1994: 57: 1689.
20. MODY CH, TOEWS GB, LIPSCOMB MF. Cyclosporine A inhibits the growth of cryptococcus neoformans in inurine model. Infect Immun 1988: 5: 6.
21. The US multicenter FK506 liver study group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110-1115.
22. European FK506 multicenter liver study group. Randomized trial comparing tacrolimus, (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994: 344: 423.
23. SINGH N, GAYOWSKI T, WAGENER MM, MARINO IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996: 61: 402.